-transparent.png){kind=logo}
The in vitro activities of eight quinolones against 115 coryneform bacteria (20 Corynebacterium jeikeium, 15 Corynebacterium minutissimum, 15 Corynebacterium striatum, 25 Corynebacterium urealyticum, 10 Corynebacterium xerosis, 10 Corynebacterium group ANF-1, 10 Corynebacterium group 12, and 10 Listeria monocytogenes) were determined. The MICs of ciprofloxacin, ofloxacin, and sparfloxacin for 90% of C. jeikeium, C. urealyticum, and C. xerosis isolates tested were > 16 micrograms/ml. Those of BAY Y 3118 and clinafloxacin against these species were 0.5 and 1 to 2 micrograms/ml, respectively. The MICs for 90% of all 115 strains tested were 0.5 microgram/ml for BAY Y 3118, 1 microgram/ml for clinafloxacin, 2 micrograms/ml for E-5068, 4 micrograms/ml for E-5065, and > 16 micrograms/ml for ciprofloxacin, ofloxacin, sparfloxacin, and E-4868.
L Martínez-Martínez, and
A I Suárez, and
M C Ortega, and
E J Perea
June 1987,
Pathologie-biologie,
L Martínez-Martínez, and
A I Suárez, and
M C Ortega, and
E J Perea
June 2001,
Antimicrobial agents and chemotherapy,
L Martínez-Martínez, and
A I Suárez, and
M C Ortega, and
E J Perea
January 1995,
Drugs,
L Martínez-Martínez, and
A I Suárez, and
M C Ortega, and
E J Perea
December 1997,
Antimicrobial agents and chemotherapy,
L Martínez-Martínez, and
A I Suárez, and
M C Ortega, and
E J Perea
January 1992,
Antimicrobial agents and chemotherapy,
L Martínez-Martínez, and
A I Suárez, and
M C Ortega, and
E J Perea
December 1993,
The Journal of antimicrobial chemotherapy,
L Martínez-Martínez, and
A I Suárez, and
M C Ortega, and
E J Perea
March 2004,
Antimicrobial agents and chemotherapy,
L Martínez-Martínez, and
A I Suárez, and
M C Ortega, and
E J Perea
December 1999,
FEMS immunology and medical microbiology,
L Martínez-Martínez, and
A I Suárez, and
M C Ortega, and
E J Perea
April 1986,
The Journal of antimicrobial chemotherapy,
L Martínez-Martínez, and
A I Suárez, and
M C Ortega, and
E J Perea
March 1992,
Antimicrobial agents and chemotherapy,
